Indanes
eMolecules 1034924-06-5 | (2-Methylpyrimidin-5-yl)boronic acid | Ambeed | MFCD07375144 | 137.930 | C5H7BN2O2 | 96.000 | Cc1ncc(cn1)B(O)O | 100mg | 525019127
(2-Methylpyrimidin-5-yl)boronic acid | Ambeed | 1034924-06-5 | MFCD07375144 | 137.930 | C5H7BN2O2 | 96.000 | Cc1ncc(cn1)B(O)O | 100mg | 525019127
Apexbio Technology LLC Atipamezole hydrochloride 104075-48-1 10mg
Atipamezole hydrochloride (CAS 104075-48-1) is a potent antagonist of 2-adrenergic receptors exhibiting a Ki value of 1 6 nM By selectively inhibiting the 2-adrenergic signaling pathway it modulates neurotransmitter release within the central nervous system Atipamezole hydrochloride is frequently utilized in neuroscience research to investigate mechanisms of noradrenergic regulation with established applications in reversal of sedative effects and evaluation of cognitive function
Medchemexpress LLC 4,6-O-Ethylidene-α-D-glucose | 13224-99-2 | 1 ML
4,6-O-Ethylidene-α-D-glucose is a glucose derivative that functions as a competitive exofacial binding-site inhibitor on glucose transporter 1 (GLUT1) with a Ki of 12 mM for wild-type 2-deoxy-D-glucose transport. It exhibits poor affinity for the malarial hexose transporter (PfHT1).
- Functions as a competitive exofacial binding-site inhibitor on glucose transporter 1 (GLUT1).
- Exhibits a Ki of 12 mM for wild-type 2-deoxy-D-glucose transport.
- Shows poor affinity for malarial hexose transporter (PfHT1).
- Supplied as a solid, white to off-white in appearance.
- Has a purity of 98.0%.
- Soluble in water and DMSO.
![eMolecules 104054-27-5 | ATIPAMEZOLE | AstaTech212.296 | C14H16N2 | 98.000 | CCC1(Cc2ccccc2C1)c1cnc[nH]1 | 0.25g | 588347105](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502172092.JPG-250.jpg)
eMolecules 104054-27-5 | ATIPAMEZOLE | AstaTech212.296 | C14H16N2 | 98.000 | CCC1(Cc2ccccc2C1)c1cnc[nH]1 | 0.25g | 588347105
ATIPAMEZOLE | AstaTech | 104054-27-5212.296 | C14H16N2 | 98.000 | CCC1(Cc2ccccc2C1)c1cnc[nH]1 | 0.25g | 588347105
Aobchem -Cyclopropyl-3-(phenylmethoxy)benzenemethanol | 95% | CAS 1857764-23-8 | C17H18O2 | 250mg
-Cyclopropyl-3-(phenylmethoxy)benzenemethanol | 95% | CAS 1857764-23-8 | C17H18O2 | 250mg
Aobchem N-(Phenylmethoxy)-4-(trifluoromethyl)benzamide | 95% | CAS 1455359-81-5 | C15H12F3NO2 | 10g
N-(Phenylmethoxy)-4-(trifluoromethyl)benzamide | 95% | CAS 1455359-81-5 | C15H12F3NO2 | 10g
Aobchem N-(Phenylmethoxy)-4-(trifluoromethyl)benzamide | 95% | CAS 1455359-81-5 | C15H12F3NO2 | 5g
N-(Phenylmethoxy)-4-(trifluoromethyl)benzamide | 95% | CAS 1455359-81-5 | C15H12F3NO2 | 5g
Medchemexpress LLC 2-Aminoindan-2-phosphonic acid | 141120-17-4 | MFCD23701560 | 213.17 | 50 MG
2-Aminoindan-2-phosphonic acid is an inhibitor of phenylalanine ammonia-lyase (PAL). It reduces the biosynthesis and accumulation of total phenolic compounds in the suspension cell culture system of Cistanche.
- Inhibits PAL activity
- Decreases accumulation of total phenolic compounds
- Decreases accumulation of Echinacoside
- Decreases accumulation of Verbascoside
- Decreases accumulation of Cistanoside A
- Decreases accumulation of Tubuloside A
- Decreases accumulation of Salidroside
Medchemexpress LLC Phosphonic acid, P-(2-amino-2,3-dihydro-1H-inden-2-yl)-, hydrochloride (1:1) | 1416354-35-2 | MFCD23135861 | 98.4% | 249.63 g/mol | C9H13ClNO3P | 50 MG
2-Aminoindan-2-phosphonic acid hydrochloride is the hydrochloride salt of 2-aminoindan-2-phosphonic acid, a competitive phenylalanine ammonia-lyase (PAL) inhibitor used in biochemical assays and plant metabolism research. It is supplied as a solid of high purity (≈98.4%) with reported formula C9H13ClNO3P and molecular weight 249.63 g/mol; documentation such as a certificate of analysis and safety data sheet is available.
- High purity solid suitable for biochemical assays and research use.
- Acts as a competitive phenylalanine ammonia-lyase (PAL) inhibitor.
- Well characterized: formula C9H13ClNO3P, molecular weight 249.63 g/mol.
- Available in small-scale quantities for laboratory research.
- Certificate of analysis and safety data sheet available for quality and handling information.
Ethos Biosciences AFB Kinyoun Methylene Blue
AFB Methylene Blue Counterstain is formulated for use as a counterstain in acid-fast staining procedures including the Kinyoun and Ziehl-Neelsen methods It provides a clear blue background that enhances contrast with the red-stained acid-fast organisms supporting accurate microscopic differentiation Designed for routine use in clinical veterinary and research laboratories this counterstain is compatible with standard acid-fast staining protocols and manual procedures The formulation delivers consistent color development and reliable performance for dependable staining results in microbiology applications
Aobchem 5-(Phenylmethoxy)-3-pyridinecarboxamide | 97% | CAS 1823479-48-6 | C13H12N2O2 | 250mg
5-(Phenylmethoxy)-3-pyridinecarboxamide | 97% | CAS 1823479-48-6 | C13H12N2O2 | 250mg
Aobchem 2-(Phenylmethoxy)-4-(trifluoromethoxy)benzaldehyde | ≥95% | CAS 1321963-80-7 | C15H11F3O3 | 500mg
2-(Phenylmethoxy)-4-(trifluoromethoxy)benzaldehyde | ≥95% | CAS 1321963-80-7 | C15H11F3O3 | 500mg
eMolecules 5400-80-6 | 2-Bromo-1-indanol | Oakwood Chemical | MFCD00003798 | 213.074 | C9H9BrO | 99.000 | OC1C(Br)Cc2ccccc12 | 1g | 537664181
2-Bromo-1-indanol | Oakwood Chemical | 5400-80-6 | MFCD00003798 | 213.074 | C9H9BrO | 99.000 | OC1C(Br)Cc2ccccc12 | 1g | 537664181
Medchemexpress LLC (1S,2R)-1-Aminoindan-2-ol | 126456-43-7 | 149.19 | 25 G
This product is a chiral resolving agent that effectively resolves various racemic 2-arylalkanoic acids and precisely controls the stereostructure of the resulting products in asymmetric syntheses. It can also be utilized in the synthesis of HIV protease inhibitors, and is used as a raw material for the production of bulk drugs and active pharmaceutical ingredients.
- Efficiently resolves racemic 2-arylalkanoic acids
- Precisely controls the stereostructure of products
- High purity (99.96%)
- Utilized in the synthesis of HIV protease inhibitors
- Used as a raw material for the production of bulk drugs
- Material produced during the synthesis of an active pharmaceutical ingredient (API) that requires further molecular change or processing to become an API
eMolecules 13171-00-1 | Celestolide | Combi-Blocks | MFCD00046324 | 244.378 | C17H24O | 98.000 | CC(=O)c1cc(cc2c1CCC2(C)C)C(C)(C)C | 1g | 117560346
Celestolide | Combi-Blocks | 13171-00-1 | MFCD00046324 | 244.378 | C17H24O | 98.000 | CC(=O)c1cc(cc2c1CCC2(C)C)C(C)(C)C | 1g | 117560346